Q2 Earnings Forecast for Allstate Issued By Zacks Research

The Allstate Corporation (NYSE:ALL) – Equities researchers at Zacks Research boosted their Q2 2026 earnings per share (EPS) estimates for Allstate in a research report issued on Wednesday, May 13th. Zacks Research analyst Team now expects that the insurance provider will post earnings of $4.38 per share for the quarter, up from their previous forecast of $3.91. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Allstate’s current full-year earnings is $28.82 per share. Zacks Research also issued estimates for Allstate’s Q3 2026 earnings at $5.28 EPS, Q4 2026 earnings at $7.89 EPS, FY2026 earnings at $28.20 EPS, Q1 2027 earnings at $7.38 EPS, Q2 2027 earnings at $5.57 EPS, Q3 2027 earnings at $5.62 EPS, FY2027 earnings at $25.93 EPS and FY2028 earnings at $21.48 EPS.

A number of other equities analysts have also recently commented on ALL. Weiss Ratings raised shares of Allstate from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 23rd. Cantor Fitzgerald restated a “neutral” rating and set a $220.00 price objective on shares of Allstate in a research report on Thursday, February 5th. Wall Street Zen downgraded shares of Allstate from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. The Goldman Sachs Group reiterated a “neutral” rating and issued a $231.00 target price on shares of Allstate in a research report on Thursday, March 5th. Finally, Citigroup raised their price target on Allstate from $221.00 to $226.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Three analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $241.67.

Allstate Stock Up 0.3%

ALL stock opened at $216.29 on Friday. The company’s 50 day moving average is $211.13 and its 200 day moving average is $206.99. The stock has a market cap of $55.68 billion, a price-to-earnings ratio of 4.77, a price-to-earnings-growth ratio of 0.39 and a beta of 0.21. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.25. Allstate has a 1-year low of $188.08 and a 1-year high of $222.23.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.31 by $3.34. Allstate had a return on equity of 42.66% and a net margin of 17.81%.The firm had revenue of $16.94 billion during the quarter, compared to the consensus estimate of $15.24 billion. During the same quarter last year, the company posted $3.53 EPS. The company’s revenue for the quarter was up 3.0% on a year-over-year basis.

Institutional Trading of Allstate

Large investors have recently modified their holdings of the business. MV Capital Management Inc. purchased a new position in Allstate during the 4th quarter valued at about $25,000. Dorato Capital Management purchased a new stake in Allstate in the 4th quarter worth approximately $27,000. Navalign LLC bought a new stake in shares of Allstate in the 4th quarter worth approximately $27,000. Evolution Wealth Management Inc. grew its position in shares of Allstate by 7,000.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock worth $29,000 after buying an additional 140 shares during the last quarter. Finally, Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of Allstate during the first quarter valued at approximately $30,000. 76.47% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Allstate news, COO Mario Rizzo sold 18,578 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $218.80, for a total transaction of $4,064,866.40. Following the completion of the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at $17,991,267.60. This represents a 18.43% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.55% of the stock is owned by insiders.

Key Headlines Impacting Allstate

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised earnings estimates for Allstate across several future periods, including FY2026 EPS to $28.20 from $23.00 and FY2027 EPS to $25.93 from $24.39, suggesting stronger profitability outlook. Allstate estimate updates
• Positive Sentiment: Recent commentary argues fears of auto-margin deterioration are overstated, pointing to resilient margins, an attractive valuation, and strong Q1 results with $10.65 EPS and a 3% revenue increase. Seeking Alpha article
• Neutral Sentiment: Zacks Research maintained a Hold rating despite the higher estimates, so the research updates are supportive but not a full bullish upgrade. Allstate analyst rating
• Negative Sentiment: Allstate is also facing legal and reputational noise after a report that it sued an alleged psychology billing scheme under federal racketeering law, which could add uncertainty even if it is not directly tied to operations. Insurance Business article

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.